Heather Orando

Heather Orando serves as a Contract Specialist responsible for managing the full lifecycle of procurement actions within a federal agency focused on pharmaceutical and medical product acquisition. She ensures compliance with federal acquisition regulations, conducts market research, develops solicitation documents, and negotiates contract terms to meet mission-critical needs. Her work directly supports the agency’s objective of securing high-quality, reliable pharmaceutical preparations through transparent, competitive processes. She typically handles complex, high-stakes acquisitions for manufactured drug products requiring stringent regulatory adherence and supply chain integrity. While no specific contractor relationships are currently identifiable in the available data, Orando engages with a broad spectrum of vendors qualified under Good Manufacturing Practices (GMP) and FDA regulatory standards. She works closely with manufacturers holding valid Drug Establishment Registrations and maintains a vendor ecosystem composed of both large-scale pharmaceutical producers and specialized contract development and manufacturing organizations (CDMOs). Her contracting approach emphasizes performance-based outcomes, quality assurance protocols, and robust contract administration to ensure consistent product efficacy and regulatory compliance. Orando’s procurement patterns reflect a strong preference for full and open competition, with 100% of her acquisitions conducted without set-aside designations such as 8(a), HUBZone, or SDVOSB. This indicates a strategic focus on maximizing technical capability and manufacturing capacity over socioeconomic targeting, aligning with the specialized nature of pharmaceutical production where scale, compliance, and regulatory expertise often outweigh small business participation metrics. Her primary procurement focus is exclusively on NAICS 325412 — Pharmaceutical Preparation Manufacturing — encompassing the acquisition of finished dosage forms, including tablets, capsules, injectables, and sterile products. She possesses deep expertise in the technical and regulatory requirements of drug manufacturing, including cGMP, stability testing, and batch release protocols, ensuring that all contracted products meet FDA and other applicable standards for safety and efficacy.